We are live on ! Find out more
BO

BRR OpCo Portfolio holdings

AUM $814M
1-Year Est. Return 9.75%
This Fund
S&P 500
This Quarter Est. Return
-10.61%
1 Year Est. Return
-9.75%
3 Year Est. Return
+23.58%
5 Year Est. Return
+36.5%
10 Year Est. Return
–
AUM
$482M
AUM Growth
-$25.1M
Cap. Flow
+$34.6M
Cap. Flow %
7.17%
Top 10 Hldgs %
80.66%
Holding
123
New
11
Increased
28
Reduced
53
Closed
14

Top Buys

Rank Stock Value
1
PXF icon
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
+$29.4M
2
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$27.1M
3
MNA icon
IQ ARB Merger Arbitrage ETF
MNA
+$4.32M
4
MLPA icon
Global X MLP ETF
MLPA
+$4.02M
5
MFEM icon
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF
MFEM
+$1.9M

Top Sells

Rank Stock Value
1
FNDF icon
Schwab Fundamental International Large Company Index ETF
FNDF
+$24.9M
2
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$3.11M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$596K
4
MSFT icon
Microsoft
MSFT
+$416K
5
IWB icon
iShares Russell 1000 ETF
IWB
+$399K

Sector Composition

Rank Sector Weight
1 Financials 24.74%
2 Technology 3.62%
3 Consumer Discretionary 2.19%
4 Healthcare 2.08%
5 Communication Services 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CERS icon
101
Cerus
CERS
$627M
$90K 0.02%
+17,713
New +$103K
SIRI icon
102
SiriusXM
SIRI
$10.3B
$57K 0.01%
1,000
– –
GSM icon
103
FerroAtlántica
GSM
$626M
$33K 0.01%
20,636
– –
SPHS
104
DELISTED
Sophiris Bio, Inc.
SPHS
$33K 0.01%
40,000
– –
CGEN icon
105
Compugen
CGEN
$224M
$22K ﹤0.01%
10,000
– –
NHLDW
106
DELISTED
National Holdings Corporation Warrants
NHLDW
$21K ﹤0.01%
48,034
– –
PVCT
107
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$2K ﹤0.01%
40,000
– –
NAVB
108
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$1K ﹤0.01%
638
– –
ADBE icon
109
Adobe
ADBE
$94.3B
– –
-922
Closed -$249K
CMCSA icon
110
Comcast
CMCSA
$85B
– –
-5,996
Closed -$212K
COP icon
111
ConocoPhillips
COP
$140B
– –
-3,811
Closed -$295K
CRSP icon
112
CRISPR Therapeutics
CRSP
$4.71B
– –
-8,478
Closed -$376K
DBEF icon
113
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9B
– –
-10,353
Closed -$335K
EFG icon
114
iShares MSCI EAFE Growth ETF
EFG
$16.4B
– –
-2,819
Closed -$226K
ISRG icon
115
Intuitive Surgical
ISRG
$122B
– –
-1,485
Closed -$284K
IWD icon
116
iShares Russell 1000 Value ETF
IWD
$81.9B
– –
-1,616
Closed -$205K
IWV icon
117
iShares Russell 3000 ETF
IWV
$19.6B
– –
-1,301
Closed -$224K
MO icon
118
Altria Group
MO
$124B
– –
-5,804
Closed -$350K
USB icon
119
US Bancorp
USB
$98.4B
– –
-4,029
Closed -$213K
VEA icon
120
Vanguard FTSE Developed Markets ETF
VEA
$226B
– –
-6,114
Closed -$265K
ESRX
121
DELISTED
Express Scripts Holding Company
ESRX
– –
-3,658
Closed -$348K
AET
122
DELISTED
Aetna Inc
AET
– –
-1,564
Closed -$317K
1 2 3 4
5

Similar funds

PS
Portfolio Solutions Royal Oak, Michigan $792M AUM 18.53% 1-Year Est. Return
CGM
Capital Growth Management Boston, Massachusetts $761M AUM 30.71% 1-Year Est. Return
AEPI
AH Equity Partners III Menlo Park, California $744M AUM 69.58% 1-Year Est. Return
FM
Forward Management San Francisco, California $907M AUM 0.46% 1-Year Est. Return
B
Brightworth Atlanta, Georgia $933M AUM 15.08% 1-Year Est. Return
RIM
Redpoint Investment Management Sydney, NSW, Australia $684M AUM 13.14% 1-Year Est. Return
FF
FourThought Financial Venice, Florida $677M AUM 12.73% 1-Year Est. Return
BCM
BTR Capital Management Oakland, California $641M AUM 9.05% 1-Year Est. Return

BRR OpCo's Q4 2018 Portfolio in Review

As of Q4 2018, BRR OpCo held 123 positions worth $482M, down 5% from $507M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

BRR OpCo deployed $34.6M of net new capital in Q4 2018, opening 11 new positions and adding to 28 existing holdings. Its largest new stake was Invesco FTSE RAFI Developed Markets ex-US ETF: 735,367 shares worth $27.6M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Schwab Fundamental International Large Company Index ETF, an estimated $24.9M trimmed.

  • BRR OpCo's largest Q4 2018 buy was Invesco FTSE RAFI Developed Markets ex-US ETF: 735,367 shares worth $27.6M.
  • BRR OpCo added most to iShares MSCI EAFE Value ETF in Q4 2018, an estimated $27.1M increase.
  • BRR OpCo's biggest Q4 2018 reduction was Schwab Fundamental International Large Company Index ETF, cutting an estimated $24.9M.
  • BRR OpCo fully exited CRISPR Therapeutics in Q4 2018, selling an estimated $376K.
  • BRR OpCo's ten largest holdings make up 81% of its $482M portfolio in Q4 2018.
  • BRR OpCo opened 11 new positions and closed 14 in Q4 2018.
  • BRR OpCo's portfolio value fell 5% quarter-over-quarter to $482M.

Based on BRR OpCo's 13F filing for Q4 2018, filed 14 Feb 2019.